These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 239444

  • 1. Binding of tritiated dehydroretronecine to macromolecules.
    Hsu IC, Robertson KA, Shumaker RC, Allen JR.
    Res Commun Chem Pathol Pharmacol; 1975 May; 11(1):99-106. PubMed ID: 239444
    [Abstract] [Full Text] [Related]

  • 2. Covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione.
    Robertson KA, Seymour JL, Hsia MT, Allen JR.
    Cancer Res; 1977 Sep; 37(9):3141-4. PubMed ID: 884667
    [Abstract] [Full Text] [Related]

  • 3. Localisation and tissue effects of tritiated dehydroretronecine in young rats.
    Shumaker RC, Hsu IC, Allen JR.
    J Pathol; 1976 May; 119(1):21-8. PubMed ID: 932871
    [Abstract] [Full Text] [Related]

  • 4. Covalent binding of two pyrrolizidine alkaloids, senecionine and seneciphylline, to hepatic macromolecules and their distribution, excretion, and transfer into milk of lactating mice.
    Eastman DF, Dimenna GP, Segall HJ.
    Drug Metab Dispos; 1982 May; 10(3):236-40. PubMed ID: 6179729
    [Abstract] [Full Text] [Related]

  • 5. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
    Xia Q, Yan J, Chou MW, Fu PP.
    Toxicol Lett; 2008 May 05; 178(2):77-82. PubMed ID: 18395999
    [Abstract] [Full Text] [Related]

  • 6. Tissue distribution, binding properties and lesions produced by dehydroretronecine in the nonhuman primate.
    Hsu IC, Robertson KA, Allen JR.
    Chem Biol Interact; 1976 Jan 05; 12(1):19-28. PubMed ID: 813833
    [Abstract] [Full Text] [Related]

  • 7. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid.
    Chou MW, Jian Y, Williams LD, Xia Q, Churchwell M, Doerge DR, Fu PP.
    Chem Res Toxicol; 2003 Sep 05; 16(9):1130-7. PubMed ID: 12971801
    [Abstract] [Full Text] [Related]

  • 8. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J, Xia Q, Chou MW, Fu PP.
    Toxicol Ind Health; 2008 Apr 05; 24(3):181-8. PubMed ID: 18842697
    [Abstract] [Full Text] [Related]

  • 9. Influence of albumin concentration, albumin species, pH and temperature on the stereoselectively different binding of (S)-(+)- and (R)-(-)-1-methyl-5-phenyl-5-propyl-barbiturate to serum albumin.
    Büch HP, Knabe J, Krug R.
    Arzneimittelforschung; 1995 Oct 05; 45(10):1049-53. PubMed ID: 8595055
    [Abstract] [Full Text] [Related]

  • 10. Differential effect of plasma protein binding of bupivacaine on its in vivo transfer into the brain and salivary gland of rats.
    Terasaki T, Pardridge WM, Denson DD.
    J Pharmacol Exp Ther; 1986 Dec 05; 239(3):724-9. PubMed ID: 3795038
    [Abstract] [Full Text] [Related]

  • 11. Comparative binding studies of anticonvulsant drugs to bovine serum albumin.
    Dal Pozzo A, Acquasaliente M, Tajana A.
    Farmaco Sci; 1983 Aug 05; 38(8):609-18. PubMed ID: 6617856
    [Abstract] [Full Text] [Related]

  • 12. Tissue distribution of tritium-labeled dehydroretronecine.
    Hsu IC, Shumaker RC, Allen JR.
    Chem Biol Interact; 1974 Mar 05; 8(3):163-70. PubMed ID: 4823118
    [No Abstract] [Full Text] [Related]

  • 13. Alkylation of N2 in deoxyguanosine by dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline.
    Robertson KA.
    Cancer Res; 1982 Jan 05; 42(1):8-14. PubMed ID: 6797726
    [Abstract] [Full Text] [Related]

  • 14. Binding of nitroreduction products of misonidazole to nucleic acids and protein.
    Varghese AJ, Whitmore GF.
    Cancer Clin Trials; 1980 Jan 05; 3(1):43-6. PubMed ID: 7389036
    [Abstract] [Full Text] [Related]

  • 15. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.
    Varghese AJ, Whitmore GF.
    Cancer Res; 1980 Jul 05; 40(7):2165-9. PubMed ID: 6155991
    [Abstract] [Full Text] [Related]

  • 16. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP, Yan J, Fu PP, Chou MW.
    Toxicol Lett; 2005 Mar 15; 155(3):411-20. PubMed ID: 15649625
    [Abstract] [Full Text] [Related]

  • 17. Crosslinking of DNA by dehydroretronecine, a metabolite of pyrrolizidine alkaloids.
    Reed RL, Ahern KG, Pearson GD, Buhler DR.
    Carcinogenesis; 1988 Aug 15; 9(8):1355-61. PubMed ID: 3402032
    [Abstract] [Full Text] [Related]

  • 18. Binding of photosensitizing dyes with some biopolymers.
    Yasui S.
    Acta Med Okayama (1952); 1970 Apr 15; 24(2):185-204. PubMed ID: 4195456
    [No Abstract] [Full Text] [Related]

  • 19. A new pyrrolizidine alkaloid metabolite, 19-hydroxysenecionine isolated from mouse hepatic microsomes in vitro.
    Eastman DF, Segall HJ.
    Drug Metab Dispos; 1982 Apr 15; 10(6):696-9. PubMed ID: 6130926
    [Abstract] [Full Text] [Related]

  • 20. Binding of globular proteins to DNA from surface tension measurement.
    Mitra A, Chattoraj DK, Chakraborty P.
    Indian J Biochem Biophys; 2001 Oct 15; 38(5):313-20. PubMed ID: 11886079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.